The presence of a significant association between elevated PRV‐1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia
Authors:
- 19 May 2003
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 70 (6) , 358-362
Abstract
Approximately 45% of newly diagnosed patients with essential thrombocythaemia (ET) demonstrate subnormal plasma erythropoietin (EPO) concentrations, which constitutes a risk factor for occlusive vascular events. In 58 ET patients, a possible association between polycythaemia rubra vera‐1 (PRV‐1) overexpression and subnormal plasma EPO was investigated, which was always measured prior to the institution of platelet lowering agents. At the time when PRV‐1 expression was measured, 28 of 58 (48%) ET patients had received platelet lowering treatment. PRV‐1 expression was measured by quantitative real‐time reverse transcription–polymerase chain reaction assay of mRNA extracted from purified peripheral blood buffy coat. The cycle threshold (CT) value of PRV‐1 was determined and was divided with the CT value for the housekeeping GAPDH gene transcript. A quotient P = 0.001). The 30 ET patients who had not received any platelet lowering treatment showed a significant (P = 0.005) relation between PRV‐1 positivity and subnormal plasma EPO. No such relationship was present in the 28 ET patients who had received prior treatment with the above drugs (P = 0.147).Keywords
This publication has 17 references indexed in Scilit:
- Monoclonal myelopoiesis and subnormal erythropoietin concentration are independent risk factors for thromboembolic complications in essential thrombocythemiaBlood, 2003
- Clonal hemopoiesis and risk of thrombosis in young female patients with essential thrombocythemiaExperimental Hematology, 2001
- Plasma Erythropoietin Concentrations in Polycythaemia Vera with Special Reference to Myelosuppressive TherapyLeukemia & Lymphoma, 2000
- Serum Erythropoietin and Thrombopoietin Levels in Patients with Essential ThrombocythaemiaLeukemia & Lymphoma, 2000
- Plasma erythropoietin by high‐detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemiaEuropean Journal of Haematology, 1998
- Are current methods of measurement of erythropoietin (EPO) in human plasma or serum adequate for the diagnosis of polycythaemia vera and the assessment of EPO deficiency?Scandinavian Journal of Clinical and Laboratory Investigation, 1998
- Diagnostic and Differential Criteria of Essential Thrombocythemia and Reactive ThrombocytosisLeukemia & Lymphoma, 1996
- Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatmentBritish Journal of Haematology, 1992
- Determination of Serum Immunoreactive Erythropoietin in the Investigation of ErythrocytosisNew England Journal of Medicine, 1986
- Pure erythrocytosis classified according to erythropoietin titersThe American Journal of Medicine, 1984